[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI832989A0 - Foerfarande foer framstaellning av benzamidderivat - Google Patents

Foerfarande foer framstaellning av benzamidderivat

Info

Publication number
FI832989A0
FI832989A0 FI832989A FI832989A FI832989A0 FI 832989 A0 FI832989 A0 FI 832989A0 FI 832989 A FI832989 A FI 832989A FI 832989 A FI832989 A FI 832989A FI 832989 A0 FI832989 A0 FI 832989A0
Authority
FI
Finland
Prior art keywords
benzamidderivat
foerfarande foer
foer framstaellning
framstaellning
foerfarande
Prior art date
Application number
FI832989A
Other languages
English (en)
Other versions
FI832989A (fi
Inventor
Michael John Ashton
David Charles Cook
Colin James Daniels
Anthony Howard Loveless
Jeremy David Pratt
Bernard Thomas Bull
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of FI832989A0 publication Critical patent/FI832989A0/fi
Publication of FI832989A publication Critical patent/FI832989A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI832989A 1982-08-24 1983-08-22 Foerfarande foer framstaellning av benzamidderivat FI832989A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8224296 1982-08-24

Publications (2)

Publication Number Publication Date
FI832989A0 true FI832989A0 (fi) 1983-08-22
FI832989A FI832989A (fi) 1984-02-25

Family

ID=10532494

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832989A FI832989A (fi) 1982-08-24 1983-08-22 Foerfarande foer framstaellning av benzamidderivat

Country Status (23)

Country Link
US (1) US4507315A (fi)
JP (1) JPS5955873A (fi)
KR (1) KR840005717A (fi)
AT (1) ATA301083A (fi)
AU (1) AU1818083A (fi)
BE (1) BE897580A (fi)
CA (1) CA1195993A (fi)
CS (1) CS240973B2 (fi)
DE (1) DE3330403A1 (fi)
DK (1) DK386783A (fi)
ES (2) ES525099A0 (fi)
FI (1) FI832989A (fi)
FR (1) FR2532310B1 (fi)
GB (1) GB2126225B (fi)
GR (1) GR78673B (fi)
IL (1) IL69544A0 (fi)
IT (1) IT1169775B (fi)
LU (1) LU84974A1 (fi)
NL (1) NL8302947A (fi)
NO (1) NO833024L (fi)
PT (1) PT77219B (fi)
SE (1) SE8304545L (fi)
ZA (1) ZA836191B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法
US4916145A (en) * 1987-07-10 1990-04-10 Hoffmann-La Roche Inc. Substituted n-[(pyridyl)alkyl]aryl-carboxamide
US4886629A (en) * 1988-06-06 1989-12-12 Allied-Signal Inc. Process for the preparation of fluorinated benzene sulfonyl fluorides
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
AU5912800A (en) * 1999-07-06 2001-01-22 Vertex Pharmaceuticals Incorporated Beta-amino acid derivatives for the treatment of neurological diseases
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
JP2008514608A (ja) * 2004-09-24 2008-05-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルホンアミド化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349124A (en) * 1957-05-20 1967-10-24 Pfizer & Co C Oral antidiabetic agent
BE756062A (fr) * 1969-09-11 1971-03-11 Boehringer Sohn Ingelheim Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
DK148576A (da) * 1975-04-18 1976-10-19 Boehringer Mannheim Gmbh Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
US4317915A (en) * 1976-08-23 1982-03-02 Hoffmann-La Roche Inc. Novel thiophene derivatives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
US4245120A (en) * 1977-09-27 1981-01-13 American Cyanamid Company 4-(Monoalkylamino)benzene polycarboxylic acids
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
LU84974A1 (fr) 1984-03-23
GR78673B (fi) 1984-09-27
GB2126225A (en) 1984-03-21
NO833024L (no) 1984-02-24
PT77219B (fr) 1986-02-04
AU1818083A (en) 1984-03-01
IT8322629A0 (it) 1983-08-24
FI832989A (fi) 1984-02-25
DK386783A (da) 1984-02-25
BE897580A (fr) 1984-02-23
JPS5955873A (ja) 1984-03-31
IT1169775B (it) 1987-06-03
KR840005717A (ko) 1984-11-16
PT77219A (fr) 1983-09-01
ZA836191B (en) 1984-04-25
CA1195993A (en) 1985-10-29
CS612483A2 (en) 1985-06-13
DK386783D0 (da) 1983-08-23
US4507315A (en) 1985-03-26
ES8502691A1 (es) 1985-01-16
CS240973B2 (en) 1986-03-13
ES528012A0 (es) 1985-06-16
FR2532310B1 (fr) 1986-01-10
SE8304545D0 (sv) 1983-08-22
ES8505935A1 (es) 1985-06-16
SE8304545L (sv) 1984-02-25
GB2126225B (en) 1985-10-09
GB8322539D0 (en) 1983-09-21
IL69544A0 (en) 1983-11-30
NL8302947A (nl) 1984-03-16
ATA301083A (de) 1985-11-15
DE3330403A1 (de) 1984-03-01
ES525099A0 (es) 1985-01-16
FR2532310A1 (fr) 1984-03-02

Similar Documents

Publication Publication Date Title
FI833952A0 (fi) Foerfarande foer paovisande av tumoerer
FI831208L (fi) Framstaellning av en gipsskiva
FI830130L (fi) Anordning foer avskiljande av vaetska
FI833044A (fi) Oxiderande sammansaettning foer faergning av haor
FI833297A0 (fi) Foerfarande foer framstaellning av sulfatcellulosa
FI832113A0 (fi) Framstaellning av vinylkarboxylsyraderivat
FI824482L (fi) Foerfarande foer foerstaerkning av fibervaevnader medelst vattenhaltiga plastdispersioner
FI64260B (fi) Anordning foer foerdelning av en stroemning
FI832403A0 (fi) Foerfarande foer isomerisering av glukos
FI821044L (fi) Taetning av ventillock
FI832349A0 (fi) Munstycksanordning foer kylning av skivor
FI830891L (fi) Foerfarande foer framstaellning av pyridinderivat
FI831406A0 (fi) Foerfarande foer framstaellning av ergolinderivat
FI831535A0 (fi) Reaktor foer framstaellning av klordioxid
FI832989A (fi) Foerfarande foer framstaellning av benzamidderivat
FI832106A0 (fi) Anordning foer aotervinning av avfallspapper
FI832362L (fi) Foerfarande foer framstaellning av fenetylaminer
FI834825A0 (fi) Foerfarande foer utvinning av sackaros
FI834620A0 (fi) Framstaellning av en fibermassa av pappersavfall
FI820403L (fi) Foerfarande foer framstaellning av betongmassa
FI65584B (fi) Anordning foer snabbkoppling av en stockbom
FI830963A0 (fi) Foerfarande foer omvandling av terpener
FI820550L (fi) Foerfarande foer styrning av manuell bearbetningsmaskin
FI831787L (fi) Anordning foer slagstansning av plaot
FI821366L (fi) Handpress foer framstaellning av brikettformigt braensle

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: MAY & BAKER LIMITED